Financial Results
Q3/2023 Results
#FutureFresenius continues to provide positive momentum: Fresenius delivers strong third quarter performance and improves operating earnings outlook
-
Application of IFRS 5: Fresenius Group financials for the first time presented excluding Fresenius Medical Care
-
Excellent Group revenue growth of 6% in constant currency to €5.5 billion driven by Operating Companies and Fresenius Vamed
-
Group EBIT increased 10% in constant currency reflecting strong performance of Operating Companies; Fresenius Vamed with operational improvement
-
Fresenius Kabi with strong organic revenue growth of 7% at top-end of structural growth band; EBIT margin remains within structural band at 14.3%
-
Fresenius Helios with strong organic revenue growth of 5% at top-end of structural growth band despite usual summer effect in Spain
-
Fresenius Vamed’s transformation progressing
-
Deconsolidation of Fresenius Medical Care effective by December 2023
-
Divestments advancing: exit of hospital operations in Peru
-
FY/23 structural productivity savings target of ~€200 million excluding Fresenius Medical Care already achieved in first nine months
-
Group revenue outlook confirmed, Group EBIT outlook improved
Selected Key Figures Q3/2023
REVENUE
€ 5518 m
+ 6% 1
Q3/22: €5,386 m
EBIT 2
€ 519 m
+10% 1
Q3/22: €480 m
CASHFLOW
€ 648 m
+8%
Q3/22: €598 m
1 In constant currency
2 Before special items
Revenue by business segment
€ in millions | Q3/23 | Q3/22 | Change | Growth at constant rates | Organic growth | Acquisitions | Divestitures | % of total revenue1 |
---|---|---|---|---|---|---|---|---|
Fresenius Kabi | 2,021 | 2,071 | -2% | 7% | 7% | 1% | 0% | 36% |
Fresenius Helios | 2,953 | 2,829 | 4% | 5% | 5% | 0% | 0% | 54% |
Fresenius Vamed | 647 | 572 | 13% | 13% | 13% | 0% | 0% | 10% |
Total | 5,518 | 5,386 | 2% | 6% | 6% | 0% | 0% | 100% |
-
1 Related to the respective external sales of the business segments. Consolidation effects and corporate entities are not taken into account. Therefore, aggregation to total Group revenue is not possible.